1. Home
  2. RNXT vs BRFH Comparison

RNXT vs BRFH Comparison

Compare RNXT & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • BRFH
  • Stock Information
  • Founded
  • RNXT 2012
  • BRFH 2005
  • Country
  • RNXT United States
  • BRFH United States
  • Employees
  • RNXT N/A
  • BRFH N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • BRFH Packaged Foods
  • Sector
  • RNXT Health Care
  • BRFH Consumer Staples
  • Exchange
  • RNXT Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • RNXT 44.0M
  • BRFH 46.2M
  • IPO Year
  • RNXT 2021
  • BRFH N/A
  • Fundamental
  • Price
  • RNXT $1.12
  • BRFH $3.31
  • Analyst Decision
  • RNXT Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • RNXT 2
  • BRFH 1
  • Target Price
  • RNXT $7.50
  • BRFH $6.00
  • AVG Volume (30 Days)
  • RNXT 579.1K
  • BRFH 18.5K
  • Earning Date
  • RNXT 11-13-2025
  • BRFH 11-06-2025
  • Dividend Yield
  • RNXT N/A
  • BRFH N/A
  • EPS Growth
  • RNXT N/A
  • BRFH N/A
  • EPS
  • RNXT N/A
  • BRFH N/A
  • Revenue
  • RNXT $662,000.00
  • BRFH $10,979,000.00
  • Revenue This Year
  • RNXT $2,895.35
  • BRFH $30.19
  • Revenue Next Year
  • RNXT $313.04
  • BRFH $76.66
  • P/E Ratio
  • RNXT N/A
  • BRFH N/A
  • Revenue Growth
  • RNXT N/A
  • BRFH 24.51
  • 52 Week Low
  • RNXT $0.75
  • BRFH $1.98
  • 52 Week High
  • RNXT $1.69
  • BRFH $6.08
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 45.33
  • BRFH 50.02
  • Support Level
  • RNXT $1.12
  • BRFH $3.10
  • Resistance Level
  • RNXT $1.15
  • BRFH $3.39
  • Average True Range (ATR)
  • RNXT 0.07
  • BRFH 0.22
  • MACD
  • RNXT -0.01
  • BRFH -0.02
  • Stochastic Oscillator
  • RNXT 28.00
  • BRFH 32.81

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: